Flow cytometric analysis of Human CD16 expression on human whole blood lymphocyte. Cells were stained with PE-conjugated anti-Human CD16. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes.
FCGR3A / CD16A Antibody (clone 41, PE)
Primary AntibodyLSBio Guarantee
| Antibody: | Mouse Monoclonal |
| Applications: | Flow Cytometry |
| Reactivity: | Human |
| Format: | Liquid |
$179.00each
Catalog Number: LS-C819668-25
Catalog Number: LS-C819668
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- CD16A antibody LS-C819668 is a PE-conjugated mouse monoclonal antibody to human CD16A (FCGR3A). Validated for Flow.
- Application
- FC
- Reactivity
- Hu
- Intended Use
- Research Use Only
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Monoclonal Antibodies
- Alternative Names
- CD16A | CD16a antigen | CD16 | FcgammaRIIIA | FCGR3A | FCR-10 | FCRIII | Fc gamma receptor III-A | Fc-gamma RIII | Fc-gamma RIII-alpha | FCG3 | IGFR3 | Fc- gamma riii | Fc-gamma receptor IIIb (CD16) | Fc-gamma RIIIa | FCGR3 | FCRIIIA | Neutrophil-specific antigen NA | Igg fc receptor iii-1 | IgG Fc receptor III-2 | Igg fc receptors iii-1 | FCGRIII
- UniProt Number
- P08637
- NCBI GenBank
- NM_000569 | NP_000560.5
- SwissProt
- P08637
Target
- Target
- Human FCGR3A / CD16A
- Antigen Species
- Human
- Epitope
- Human CD16a
- Gene Name
- FCGR3A
Antibody
- Host Species
- Mouse
- Clonality
- Monoclonal
- Clone
- 41
- Isotype
- IgG1
- Origin Species
- Human
Immunogen
- Immunogen
- Recombinant Human CD16a protein
- Immunogen Type
- Recombinant Immunogen
Format
- Conjugate/Label
- Phycoerythrin
- Format
- Liquid
- Formulation
- Aqueous solution containing 0.5% BSA and 0.03% ProClin 300
- Concentration
- 0.1 mg/mL
- Preservative
- Yes
- Purification Method
- Protein A Affinity
Storage & Handling
- Storage Conditions
- Store at 2°C to 8°C for up to 1 year. Protect from light. Do not freeze.